- Thermo Fisher Scientific (NYSE:TMO): Q2 Non-GAAP EPS of $5.60 beats by $0.12; GAAP EPS of $4.61 beats by $0.34.
- Revenue of $9.27B (+34.0% Y/Y) beats by $540M.
- Thermo Fisher is raising its 2021 revenue and earnings guidance. The company is raising its revenue guidance by $300 million to $35.90 billion ($35.65B consensus); this would result in 11% revenue growth over 2020. The company is raising its adjusted EPS guidance by $0.10 to $22.07 ($22.11 consensus), which would represent 13% growth year over year.
- Press Release